Status:
COMPLETED
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.
Lead Sponsor:
GCS Ramsay Santé pour l'Enseignement et la Recherche
Conditions:
Glioma
Eligibility:
All Genders
18+ years
Brief Summary
From the medical records of a series of patients operated on for incident grade II and III glioma, the primary objective is to evaluate the correlation between the molecular profile of tumours and pre...
Detailed Description
A retrospective monocentre study of medical data (clinical, histological, molecular and imaging) contained in the medical records of patients operated on for Grade II or III incident glioma.
Eligibility Criteria
Inclusion
- Subject 18 years of age or older, having been informed of the research
- Subject operated on with an incident glioma of grade II or III, histologically confirmed (WHO 2016 classification)
- Subject for which all preoperative imaging data is available (MRI, FDG and FDOPA PET-scan)
- Subject for which molecular data of the lesion are available
Exclusion
- Subject having signified his opposition to the use of his medical data
- Subject under safeguard of justice, guardianship or trusteeship
- Subject with incomplete or missing part of the molecular and/or imaging data
Key Trial Info
Start Date :
September 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04461002
Start Date
September 30 2019
End Date
June 30 2024
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé Clairval
Marseille, France, 13009